| Patent No. | Patent Title: |
| 8007799 | Vascular endothelial cell growth factor antagonists and uses ther... |
| 7998931 | Vascular endothelial cell growth factor antagonists and uses ther... |
| 7981692 | Immunoassays to detect diseases or disease susceptibility traits |
| 7951917 | Method for making multispecific antibodies having heteromultimeri... |
| 7939080 | HER-2 binding antagonists |
| 7935350 | Ii-key/Her-2/neu hybrid cancer vaccine |
| 7932360 | Recombinant production of mixtures of antibodies |
| 7892542 | Human anti-idiotypic antibody fragments that mimic HER-2/neu |
| 7892549 | Treatment with anti-ErbB2 antibodies |
| 7892554 | Internalizing ErbB2 antibodies |
| 7887808 | Human Rgr oncogene and truncated transcripts thereof detected in ... |
| 7883702 | Use of anti-mortalin 2 antibody and functional nucleic acid for c... |
| 7879327 | Medicament for treating cancer |
| 7867717 | Immunoassays to detect diseases or disease susceptibility traits |
| 7862817 | Humanized anti-ErbB2 antibodies and treatment with anti-ErbB2 ant... |
| 7858760 | Antibodies to protein expressed in prostate cancer |
| 7846441 | Treatment with anti-ErbB2 antibodies |
| 7842461 | CD38 as a prognostic indicator in B cell chronic lymphocytic leuk... |
| 7824680 | Methods for inhibiting angiogenesis |
| 7820447 | Compositions and methods for cancer |
| 7820180 | -based and LLO-based vaccines |
| 7794729 | Methods and compositions for immunotherapy of cancer |
| 7771958 | Method for predicting response to epidermal growth factor recepto... |
| 7763461 | Antitumor vaccination using allogeneic tumor cells expressing alp... |
| 7745165 | Phosphatase associated with metastasis |
| 7732588 | Tweak receptor |
| 7700299 | Method for predicting the response to a treatment |
| 7695962 | Polypeptides and nucleic acids encoding same |
| 7666587 | Method of screening test substances for treating or preventing a ... |
| 7655239 | Immune reactivity to HER-2/protein for diagnosis and treatment of... |
| 7635475 | Diabody-type bispecific antibody |
| 7625859 | HER-2 binding antagonists |
| 7618631 | Treatment with anti-ErbB2 antibodies and EGFR-targeted drugs |
| 7608269 | Compositions and methods for treating cancer by modulating HER-2 ... |
| 7605003 | Use of biomarkers for detecting ovarian cancer |
| 7585509 | Erb-2 receptor targeting peptide |
| 7575923 | CD19xCD3 specific polypeptides and uses thereof |
| 7572798 | Combi-molecules having signal transduction inhibitory properties ... |
| 7566542 | Use of protein ASC as a marker for breast cancer |
| 7537931 | Humanized anti-ERBB2 antibodies and treatment with anti-ERBB2 ant... |
Bizarre Patents 
PatentStorm News
